Nona Bioscience appoints Hong Di as Chief Executive Officer

Zhitong
2025.10.15 07:10

On October 15th, Nona Bioscience announced the appointment of Hong Di as Chief Executive Officer. Hong Di will be based in Shanghai and report directly to Nona Bioscience Chairman Wang Jinsong. Prior to joining Nona Bioscience, he served as the CEO of Hillhouse Capital's life sciences infrastructure platform, GaoYue Group, and held senior management positions at HUA MEDICINE, Bounteous-San Diego, Amgen, Eli Lilly, and Roche

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer